ARCHIVES

No Interest Seen Yet In Specialized Centers For Environmental Carcinogenesis

This article is from The Cancer Letter archive.

Vol. 01 No. 39 | September 26, 1975

Download PDF Visit The Full Archive

Related Articles

Lombardi Center Officials Say New Partnership To Provide For Expansion In Services, Patients.

February 23, 2001

First-Line Tarceva Nearly Doubles PFS in EGFR-Activated Tumors

June 24, 2011

FDA Advisors Okay DDC For AIDS Treatment In Comb With AZT

May 8, 1992

MGI Pharma’s Irofulven In Phase III Trial Vs. 5-FU For Advanced Pancreatic Cancer.

March 2, 2001

Cancer Letter On Vacation

August 3, 1984

FDA Approves Velcade Injection In Mantle Cell Lymphoma

October 31, 2014